Literature DB >> 2159093

The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases.

B W Scheithauer1, T Sano, K T Kovacs, W F Young, N Ryan, R V Randall.   

Abstract

A histologic and immunocytochemical study of 69 autopsy-obtained pituitaries from women who died during pregnancy, after abortion, or in the postpartum period revealed an accumulation of large chromophobic to slightly acidophilic and periodic acid-Schiff-negative pregnancy cells that were immunoreactive for prolactin but not for other pituitary hormones. This increase in the number of prolactin cells was confirmed by cell counts. Thus, pregnancy cells are capable of prolactin production. The finding of mitotic figures in such cells supports the view that they arise by multiplication from preexisting prolactin cells. With use of "mirror section" techniques, no mammosomatotrophs (cells immunoreactive for growth hormone and prolactin) were identified. Hyperplasia of prolactin cells was evident at 1 month of pregnancy and gradually disappeared within several months after delivery or abortion; the process of involution seemed to be retarded in the one lactating patient investigated. In some pituitaries, the accumulation of prolactin cells was so extensive that the hyperplastic foci resembled microadenomas. Another striking change in the pituitaries of pregnant women was appreciable reduction of immunostaining of gonadotropic cells, a process that was reversible as soon as 1 month after delivery. Among the 69 pituitaries studied, 8 noninvasive microadenomas (12%) were encountered (7 contained prolactin only and 1 was plurihormonal). Prolactin-producing adenomas were no more numerous or larger than were similar tumors encountered in nonpregnant women or normal men; thus, pregnancy neither initiates formation of pituitary adenomas nor accelerates their growth. In the pituitaries that harbored prolactin-producing adenomas, massive pregnancy cell hyperplasia was evident outside the tumor; thus, prolactin production by adenoma cells did not seem to suppress the proliferation of prolactin-containing pregnancy cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159093     DOI: 10.1016/s0025-6196(12)60946-x

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  43 in total

Review 1.  Aspects of anterior pituitary growth, with special reference to corticotrophs.

Authors:  A M McNicol; E Carbajo-Perez
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

Review 2.  Medical management of prolactin-secreting pituitary adenomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

3.  Vascularity in Nontumorous Human Pituitaries and Incidental Microadenomas: A Morphometric Study.

Authors:  Sergio Vidal; Bernd W. Scheithauer; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

Review 4.  Sheehan's syndrome.

Authors:  Fahrettin Keleştimur
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

5.  Anesthetic management of a parturient for combined cesarean section and surgical removal of pituitary tumor -A case report-.

Authors:  Ji-Hyun Chung; Jeong-Ho Rho; Tae-Hyeng Jung; Seung-Cheol Cha; Han-Kil Jung; Cheong Lee; Seong-Chang Woo
Journal:  Korean J Anesthesiol       Date:  2012-06-19

Review 6.  Pregnancy-associated Cushing's disease? An exploratory retrospective study.

Authors:  Sheri K Palejwala; Andrew R Conger; Amy A Eisenberg; Pejman Cohan; Chester F Griffiths; Garni Barkhoudarian; Daniel F Kelly
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

Review 7.  Prolactinomas and pregnancy.

Authors:  Marcello Delano Bronstein
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

8.  T1 signal intensity and height of the anterior pituitary in neonates: correlation with postnatal time.

Authors:  E Kitamura; Y Miki; M Kawai; H Itoh; S Yura; N Mori; K Sugimura; K Togashi
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-16       Impact factor: 3.825

Review 9.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

Review 10.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.